Literature DB >> 31953548

[Pathology of liver tumors].

P Schirmacher1.   

Abstract

Based on recent advances in morphological and molecular research, tissue-based diagnostics of liver tumors exhibit a substantial dynamic. New clinically relevant tumor subtypes have been defined and the diagnostic criteria have been improved; examples are the new morphomolecular classifications of hepatocellular carcinoma and adenoma as well as intrahepatic cholangiocarcinoma. Therefore, molecular pathological diagnostics are gaining relevance in the identification of tumor types and therapeutic stratification. These developments are reflected in the new World Health Organization (WHO) classification of hepatobiliary tumors and the respective clinical practice guidelines.

Entities:  

Keywords:  Cholangiocarcinoma, intrahepatic; Hepatocellular Adenoma; Hepatocellular Carcinoma; Liver Biopsy; Molecular Pathology

Mesh:

Year:  2020        PMID: 31953548     DOI: 10.1007/s00108-019-00729-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  10 in total

1.  The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.

Authors:  Luca Di Tommaso; Annarita Destro; Jae Yeon Seok; Emanuela Balladore; Luigi Terracciano; Angelo Sangiovanni; Massimo Iavarone; Massimo Colombo; Ja June Jang; Eunsil Yu; So Young Jin; Emanuela Morenghi; Young Nyun Park; Massimo Roncalli
Journal:  J Hepatol       Date:  2008-12-25       Impact factor: 25.083

2.  Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia.

Authors: 
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 3.  Hamartomas and malformations of the liver.

Authors:  Michael S Torbenson
Journal:  Semin Diagn Pathol       Date:  2018-11-17       Impact factor: 3.464

Review 4.  Emerging Role of the Pathologist in Precision Medicine for HCC.

Authors:  Thomas Longerich; Peter Schirmacher
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

5.  Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.

Authors:  Jean Charles Nault; Julien Calderaro; Luca Di Tommaso; Charles Balabaud; Elie Serge Zafrani; Paulette Bioulac-Sage; Massimo Roncalli; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2014-10-27       Impact factor: 17.425

6.  Liver cancer biopsy--back to the future?!

Authors:  Michael Torbenson; Peter Schirmacher
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

Review 7.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

Review 8.  Hepatocellular adenoma: Classification, variants and clinical relevance.

Authors:  Paulette Bioulac-Sage; Christine Sempoux; Charles Balabaud
Journal:  Semin Diagn Pathol       Date:  2016-12-20       Impact factor: 3.464

Review 9.  Terminology of nodular hepatocellular lesions.

Authors: 
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

10.  Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.

Authors:  Jean-Charles Nault; Gabrielle Couchy; Charles Balabaud; Guillaume Morcrette; Stefano Caruso; Jean-Frederic Blanc; Yannick Bacq; Julien Calderaro; Valérie Paradis; Jeanne Ramos; Jean-Yves Scoazec; Viviane Gnemmi; Nathalie Sturm; Catherine Guettier; Monique Fabre; Eric Savier; Laurence Chiche; Philippe Labrune; Janick Selves; Dominique Wendum; Camilla Pilati; Alexis Laurent; Anne De Muret; Brigitte Le Bail; Sandra Rebouissou; Sandrine Imbeaud; Paulette Bioulac-Sage; Eric Letouzé; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2016-12-07       Impact factor: 22.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.